Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transport proteins are a vast group of membrane-bound proteins that facilitate the movement of ions, small molecules, and macromolecules across biological membranes, which are otherwise impermeable to many polar or large substances (Wikipedia; Study.com). This broad classification includes several major superfamilies, most notably the solute carriers (SLC), ATP-binding cassette (ABC) transporters, and various ion channels and pumps (PMC; Tocris Bioscience). These proteins are essential for fundamental cellular processes such as nutrient uptake, waste excretion, signal transduction, and the maintenance of electrochemical gradients (Longdom Publishing; bioRxiv). Because they regulate the entry and exit of substances, they are primary determinants of drug pharmacokinetics, influencing how medications are absorbed, distributed, and eventually cleared from the body (Vertex; eLife). Dysfunctions in transport proteins are linked to a wide range of pathologies, including genetic disorders like cystic fibrosis, metabolic diseases like diabetes, and the development of multidrug resistance in cancer (PMC; Vrije Universiteit Brussel). Consequently, specific members of this class are high-value therapeutic targets for a diverse array of drugs, including SGLT2 inhibitors for diabetes, SSRIs for depression, and diuretics for hypertension (PMC; Tocris Bioscience; PMC).
Drugs targeting these proteins typically act by inhibiting the translocation of substrates through competitive or non-competitive binding, occluding pores, or modulating ATPase activity in primary active transporters (PMC; Tocris Bioscience).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transport protein.